[1]
“DEVELOPMENT OF BIODEGRADABLE NANOCARRIERS FOR TARGETED DRUG DELIVERY IN OVARIAN CANCER”, FMHR, vol. 3, no. 7, pp. 500–513, Sep. 2025, Accessed: Aug. 12, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/1116